News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
52,216 Results
Type
Article (3338)
Company Profile (10)
Press Release (48868)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (12945)
Career Advice (36)
Deals (1981)
Drug Delivery (8)
Drug Development (8082)
Employer Resources (7)
FDA (2296)
Job Trends (1456)
News (25910)
Policy (2398)
Tag
2024 Biotech Bay Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
2026 Bio NC Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (203)
Adcomms (2)
Allergies (6)
Alliances (3824)
ALS (2)
Alzheimer's disease (88)
Antibody-drug conjugate (ADC) (2)
Approvals (2305)
Artificial intelligence (21)
Autoimmune disease (1)
Bankruptcy (17)
Best Places to Work (1332)
Biosimilars (6)
Biotechnology (8)
Bladder cancer (1)
Breast cancer (14)
Cancer (92)
Cardiovascular disease (162)
Career advice (35)
Career pathing (1)
CAR-T (1)
Cell therapy (12)
Clinical research (7127)
Collaboration (60)
Compensation (13)
Complete response letters (2)
COVID-19 (145)
CRISPR (5)
C-suite (16)
Data (238)
Depression (2)
Diabetes (58)
Diagnostics (334)
Digital health (2)
Diversity, equity & inclusion (3)
Drug discovery (7)
Drug pricing (11)
Drug shortages (4)
Duchenne muscular dystrophy (13)
Earnings (4470)
Employer branding (1)
Employer resources (7)
Events (6317)
Executive appointments (67)
FDA (2419)
Featured Employer (4)
Funding (38)
Gene editing (10)
Generative AI (1)
Gene therapy (26)
GLP-1 (169)
Government (249)
Guidances (4)
Healthcare (988)
IgA nephropathy (3)
Immunology and inflammation (10)
Indications (2)
Infectious disease (152)
Inflammatory bowel disease (7)
Influenza (2)
Intellectual property (10)
Interviews (4)
IPO (715)
IRA (4)
Job creations (218)
Job search strategy (33)
Layoffs (25)
Legal (338)
Liver cancer (6)
Lung cancer (22)
Lymphoma (7)
Machine learning (1)
Management (2)
Manufacturing (18)
MASH (20)
Medical device (1389)
Medtech (1389)
Mergers & acquisitions (1296)
Metabolic disorders (161)
Multiple sclerosis (2)
NASH (7)
Neurodegenerative disease (5)
Neuropsychiatric disorders (3)
Neuroscience (110)
NextGen: Class of 2025 (298)
Non-profit (229)
Northern California (236)
Now hiring (1)
Obesity (90)
Opinion (13)
Ovarian cancer (3)
Pain (5)
Pancreatic cancer (4)
Parkinson's disease (5)
Partnered (1)
Patents (13)
Patient recruitment (9)
Peanut (4)
People (4129)
Pharmaceutical (3)
Phase I (1401)
Phase II (2565)
Phase III (3152)
Pipeline (103)
Policy (10)
Postmarket research (575)
Preclinical (586)
Prostate cancer (8)
Psychedelics (4)
Radiopharmaceuticals (10)
Rare diseases (24)
Real estate (317)
Recruiting (2)
Regulatory (2017)
Reports (5)
Research institute (180)
Resumes & cover letters (1)
RNA editing (1)
RSV (1)
Schizophrenia (8)
Series A (8)
Series B (5)
Sickle cell disease (3)
Southern California (95)
Special edition (1)
Spinal muscular atrophy (18)
Sponsored (1)
Startups (241)
Supply chain (4)
Tariffs (3)
The Weekly (8)
United States (1637)
Vaccines (23)
Weight loss (56)
Women's health (2)
Date
Today (16)
Last 7 days (61)
Last 30 days (205)
Last 365 days (2487)
2025 (763)
2024 (2591)
2023 (2748)
2022 (4318)
2021 (4137)
2020 (3547)
2019 (3022)
2018 (2088)
2017 (2384)
2016 (2398)
2015 (2868)
2014 (2286)
2013 (1916)
2012 (2080)
2011 (2197)
2010 (2260)
Location
Africa (41)
Arizona (6)
Asia (3308)
Australia (453)
California (378)
Canada (130)
China (76)
Colorado (19)
Connecticut (4)
Delaware (26)
Europe (7664)
Florida (89)
Georgia (9)
Illinois (36)
India (4)
Indiana (20)
Japan (23)
Kansas (4)
Kentucky (1)
Maryland (34)
Massachusetts (330)
Michigan (9)
Minnesota (41)
Mississippi (1)
Missouri (4)
Nevada (5)
New Hampshire (3)
New Jersey (164)
New Mexico (2)
New York (180)
North Carolina (116)
Northern California (236)
Ohio (15)
Oregon (3)
Pennsylvania (74)
South America (73)
South Carolina (3)
Southern California (95)
Tennessee (11)
Texas (42)
Utah (10)
Virginia (8)
Washington D.C. (2)
Washington State (32)
West Virginia (1)
52,216 Results for "cormatrix cardiovascular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in development to date” in the competitive Lp(a) space, where drugs are designed to lower the risk of cardiovascular events such as heart attack and stroke.
March 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Atherosclerotic Cardiovascular Disease Market Size to Reach USD 30.6 Billion by 2035, Impelled by Advancements in Novel Drug Therapies
Atherosclerotic Cardiovascular Disease Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Press Releases
Semaglutide 2.4 mg reduces burden of total cardiovascular events in people with established cardiovascular disease and overweight or obesity
March 31, 2025
·
9 min read
Press Releases
Anumana Expands AI Platform from Diagnostic Solutions to the Full Continuum of Cardiovascular Care
April 24, 2025
·
3 min read
Cardiovascular disease
Deep Dive: Cardiovascular Disease Back in the Spotlight
In this deep dive,
BioSpace
explores the diverse therapeutic modalities now in development, as well as the opportunities and battles for market dominance in this emerging space.
March 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
April 17, 2025
·
4 min read
Press Releases
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
April 1, 2025
·
11 min read
Press Releases
Prolocor(R) Announces Publication in Circulation: Cardiovascular Interventions. Results Demonstrate That the Prolocor pFCG(TM) Test Predicts Risk of Subsequent Cardiovascular Events Regardless of Treatment Strategy (Percutaneous Coronary Intervention or Medical Management Alone)
March 31, 2025
·
4 min read
Press Releases
Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease
April 15, 2025
·
2 min read
Press Releases
Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25
March 27, 2025
·
3 min read
1 of 5,222
Next
